期刊文献+

特比萘芬与氟康唑或伊曲康唑联合对氟康唑诱导耐药稳定白念珠菌的影响 被引量:5

Synergisic effects of terbinafine combined with fluconazole or itraconazole on stable fluconazole-resistant Candida albicans induced by fluconazole in vitro
原文传递
导出
摘要 目的探讨特比萘芬与氟康唑或伊曲康唑联合抗氟康唑诱导产生的耐药稳定白念珠菌的作用。方法采用多步诱导法,在YEPD培养基中,利用氟康唑诱导白念珠菌敏感株产生耐药稳定菌株。根据美国国家临床实验标准委员会(NCCLS)制定的标准,采用棋盘微量稀释法测定特比萘芬与氟康唑或伊曲康唑对耐药稳定菌株的联合药敏试验,并对诱导耐药稳定菌株ERG11基因的编码区序列进行 DNA测序。结果临床敏感菌株和标准敏感菌株能被诱导形成耐药菌株,但大部分不稳定,诱导耐药稳定株ERG11基因的编码区DNA测序有突变点存在,特比萘芬与氟康唑或伊曲康唑联用对诱导耐药稳定株可产生协同作用。结论特比萘芬与氟康唑或伊曲康唑联合应用对基因突变产生的耐药株有协同作用,可阻止或延迟氟康唑诱导的耐药性白念珠菌菌株的产生。 Objective To investigate the effects of terbinafine combined with flueonazole or itraconazole on stable fluconazole-resistant Candida albicans induced by fluconazole in vitro. Methods Eleven fluconazole-sensitive isolates were serially subcultured in YEPD medium containing different concentrations of fluconazole to induce stable flueonazole-resistant strains (MIC≥ 128 μg/ml). The checkerboard microdilution method was applied according to M27-A to study the interaction of terbinafine with fluconazole or itraconazole against stable fluconazole-resistant strains in vitro. Nucleotide sequence of the encoded region in ERG11 genes of stable fluconazole resistant strains was examined. Results Resistant strains were induced by fluconazole in 11 fluconazole-sensitive isolates but most were not stable. Mutations were detected in the nucleotide sequence of the encoded region in ERGI 1 of the stable drug acquired resistant isolates. The synergy in terbinafine-fluconazale or itraconazole interaction was observed in stable drug acquired resistant isolates. Conclusion The combinations of terbinafine and fluconazole or itraconazole can show synergisic antifungal effects on fluconazole-resistant mutants.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2006年第4期360-364,共5页 Chinese Journal of Microbiology and Immunology
关键词 白念珠菌 氟康唑 伊曲康唑 特比萘芬 Candida albicans Fluconazole Itraconazole Terbinafme
  • 相关文献

参考文献19

  • 1Czaika V,Tietz HJ,Schmalreck A,et al.Antifungal susceptibility testing in chronically recurrent vaginal candidiasis as basis for effective therapy.Mycoses,2000,43(suppl 2):45-50.
  • 2Evans EG.Resistance of Candida species to antifungal agent used in the treatment of onychomycosis:a review of current problems.Br J Dermatol,1999,141(Suppl 56):33-35.
  • 3Mosquera J,Sharp A,Moore CB,etal.Invitro interaction of terbinafine with itraconazole,fluconazole,amphotericin B and 5-flucytosine against Aspergillus spp.J Antimicrob Chemother,2002,50(2):189-194.
  • 4Te Dorsthorst DT,Verweij PE,Meis JF,et al.Comparison of fractional inhibitory concentration index with response surface modeling for characterization ofin vitro interactinn of antifungals ngaint itraconazole-susceptible and -resistant Aspergillus fumigarus isolates.Antimicrob Agents Chemother,2002,46(3):702-707.
  • 5Weig M,Muller FM.Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.Antimicrob Agents Chemother,2001,45(3):966-968.
  • 6肖异珠,李桂明.尼克霉素Z与氟康唑或特比萘芬抗白念珠菌的体外实验[J].中华皮肤科杂志,2001,34(5):379-379. 被引量:14
  • 7Ghannoum MA,Elewski B.Successful treatment of fluconazole-resistant oropharyngeal candidiasis by a combination of fiuconazole and terbinafine.Clin Diagn Lab Immunol,1999,6(6):921-923.
  • 8National Committee for Clinical Laboratory Standards.Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard M27-a Villanova.NCCLS,1997,17(9):ⅩⅤ.
  • 9Cowen LE,Sanglard D,Calabrese D,et al.Evolution of drug resistance in experimental populations of Candida albicans.Antimicrob Agents Chemother,2000,182(6):1515-1522.
  • 10Mosquera J,Sharp A,Moore CB,et al.In vitro interaction of terbinafine with itraconazole,fluconazole,amphotericin B and 5-flucytosine against Aspergillus spp.J Antimicrob Chemother,2002,50(2):189-194.

二级参考文献5

共引文献26

同被引文献39

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部